271 related articles for article (PubMed ID: 21397595)
1. Effects of specific prostanoid EP receptor agonists on cell proliferation and intracellular Ca(2+) concentrations in human airway smooth muscle cells.
Mori A; Ito S; Morioka M; Aso H; Kondo M; Sokabe M; Hasegawa Y
Eur J Pharmacol; 2011 May; 659(1):72-8. PubMed ID: 21397595
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
[TBL] [Abstract][Full Text] [Related]
3. E-prostanoid (EP)2/EP4 receptor-dependent maturation of human monocyte-derived dendritic cells and induction of helper T2 polarization.
Kubo S; Takahashi HK; Takei M; Iwagaki H; Yoshino T; Tanaka N; Mori S; Nishibori M
J Pharmacol Exp Ther; 2004 Jun; 309(3):1213-20. PubMed ID: 14872092
[TBL] [Abstract][Full Text] [Related]
4. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium.
Cao J; Shayibuzhati M; Tajima T; Kitazawa T; Taneike T
Eur J Pharmacol; 2002 May; 442(1-2):115-23. PubMed ID: 12020689
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
[TBL] [Abstract][Full Text] [Related]
6. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
[TBL] [Abstract][Full Text] [Related]
7. Effects of prostanoid EP agonists on mouse intraocular pressure.
Saeki T; Ota T; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
9. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
[TBL] [Abstract][Full Text] [Related]
10. Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells.
Wise H
Eur J Pharmacol; 2006 Mar; 535(1-3):69-77. PubMed ID: 16545798
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites.
Bradbury D; Clarke D; Seedhouse C; Corbett L; Stocks J; Knox A
J Biol Chem; 2005 Aug; 280(34):29993-30000. PubMed ID: 15970595
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression, cytokine production, and lymphocyte proliferation in human peripheral blood mononuclear cells.
Takahashi HK; Liu K; Wake H; Mori S; Zhang J; Liu R; Yoshino T; Nishibori M
J Pharmacol Exp Ther; 2009 Nov; 331(2):656-70. PubMed ID: 19700629
[TBL] [Abstract][Full Text] [Related]
15. EP4 receptor mediation of prostaglandin E2-stimulated mucus secretion by rabbit gastric epithelial cells.
Takahashi S; Takeuchi K; Okabe S
Biochem Pharmacol; 1999 Dec; 58(12):1997-2002. PubMed ID: 10591156
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 (PGE2) downregulates interleukin (IL)-1alpha-induced IL-6 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells.
Noguchi K; Maeda M; Ruwanpura SM; Ishikawa I
Oral Dis; 2005 May; 11(3):157-62. PubMed ID: 15888106
[TBL] [Abstract][Full Text] [Related]
17. Involvement of postsynaptic EP4 and presynaptic EP3 receptors in actions of prostaglandin E2 in rat supraoptic neurones.
Shibuya I; Setiadji SV; Ibrahim N; Harayama N; Maruyama T; Ueta Y; Yamashita H
J Neuroendocrinol; 2002 Jan; 14(1):64-72. PubMed ID: 11903814
[TBL] [Abstract][Full Text] [Related]
18. Role of EP2 receptors and cAMP in prostaglandin E2 regulated expression of type I collagen alpha1, lysyl oxidase, and cyclooxygenase-1 genes in human embryo lung fibroblasts.
Choung J; Taylor L; Thomas K; Zhou X; Kagan H; Yang X; Polgar P
J Cell Biochem; 1998 Nov; 71(2):254-63. PubMed ID: 9779823
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression on monocytes, cytokine production, and lymphocyte proliferation during human mixed lymphocyte reaction.
Takahashi HK; Zhang J; Mori S; Liu K; Wake H; Liu R; Sadamori H; Matsuda H; Yagi T; Yoshino T; Nishibori M
J Pharmacol Exp Ther; 2010 Sep; 334(3):964-72. PubMed ID: 20558773
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
